Chris Lindblom is Vice President of Finance and Treasurer at Cogen Therapeutics with over 17 years of life science finance expertise. He is a member of the executive management team and trusted advisor to the C-suite and board of directors on a wide range of financial and operating issues. He also develops, influences and executes overall company strategy as a team leader and mentor.
Chris has a proven track record of leadership within the life sciences industry, including Millennium Pharmaceuticals, Warp Drive Bio (Third Rock Ventures), Infinity Pharmaceuticals and BIND Therapeutics. During his tenure as Vice President of Finance and Operations at Warp Drive Bio, Inc. he worked closely with the CEO during the Series B equity raise process and ultimately the M&A with Revolution Medicines.